Læknablaðið - 15.06.2007, Síða 2

SPIRIVA (TIOTROPIUM)
Meira lolt í lungun
Frelsi
SPIRIVAR
er grunnurinn í
meðhöndlun á LLT12)
A Minnkar mæði við áreynslu3'
A Eykur úthald við áreynslu3’
A Fækkar versnunum og innlögnum
vegna þeirra41
A Eykur lífsgæði sjúklings51
Hcimildir: I) Medicinsk Kompendium 2004; bls 1331. 2) Tashkin et al. Review.The Role of Long-Acting Bronchodilators in the Management of Stable COPD. CHEST 2004;125:249-259. 3) O'Donnell et al. Effects of tiotropium on lung hyperinflatior
dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23:832-840. 4) Casaburi et al.A long-term evaluation of once daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19:217-224. 5) Vincken et al. Improved healt
outcomes in patients with COPD during I years treatment with tiotropium. Eur Respir J 2002;19:209-216.
Sérlyfjatexti á bls. 516
Umboðsaðili:Vistor hf.
Hörgatúni 2, 2I0 Garðabær
Sími: 535 7000, www.pfizer.is
Boehringf
Ingelheim